NRX Pharmaceuticals Stock (NASDAQ: NRXP) stock price, news, charts, stock research, profile.
Open | - |
Close | - |
Volume / Avg. | 72.692K / 1.454M |
Day Range | - - - |
52 Wk Range | 0.221 - 1.200 |
Market Cap | $48.986M |
P/E Ratio | - |
Dividend Yield | - |
Exchange | NASDAQ |
RSI | 51 |
Short Interest | 6.02% |
Days to Cover | 4.18 |
Name |
---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
You can purchase shares of NRX Pharmaceuticals (NASDAQ: NRXP) through any online brokerage.
Other companies in NRX Pharmaceuticals’s space includes: Cumberland (NASDAQ:CPIX), SCYNEXIS (NASDAQ:SCYX), CalciMedica (NASDAQ:CALC), Ocuphire Pharma (NASDAQ:OCUP) and Rani Therapeutics Hldgs (NASDAQ:RANI).
The latest price target for NRX Pharmaceuticals (NASDAQ: NRXP) was reported by HC Wainwright & Co. on Thursday, May 25, 2023. The analyst firm set a price target for 2.00 expecting NRXP to rise to within 12 months (a possible 277.36% upside). 1 analyst firms have reported ratings in the last year.
The stock price for NRX Pharmaceuticals (NASDAQ: NRXP) is $0.53 last updated Today at March 28, 2024 at 8:54 AM EDT.
There are no upcoming dividends for NRX Pharmaceuticals.
NRX Pharmaceuticals’s Q1 earnings are confirmed for Tuesday, May 14, 2024.
The stock split for NRXP was announced on Thursday, March 28, 2024. The date this stock split will start trading, also known as the ex-date, will be on Tuesday, April 2, 2024.
NRX Pharmaceuticals is in the Health Care sector and Pharmaceuticals industry. They are listed on the NASDAQ.